Showing 1 - 18 results of 18 for search 'Nicholas M. Barnes', query time: 0.07s
Refine Results
-
1
Impact of a varied set of stimuli on a suite of immunological parameters within peripheral blood mononuclear cells: toward a non-animal approach for assessing immune modulation by... by Stella Cochrane, Ramya Rajagopal, David Sheffield, Fay Stewart, Lindsay Hathaway, Nicholas M. Barnes, Nicholas M. Barnes, Omar Qureshi, John Gordon
Published 2024-04-01
Article -
2
-
3
-
4
A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis. by Ann Logan, Zsuzsanna Nagy, Nicholas M Barnes, Antonio Belli, Valentina Di Pietro, Barbara Tavazzi, Giuseppe Lazzarino, Giacomo Lazzarino, Lars Bruce, Lennart I Persson
Published 2022-01-01
Article -
5
Low Molecular Weight Dextran Sulfate (ILB<sup>®</sup>) Administration Restores Brain Energy Metabolism Following Severe Traumatic Brain Injury in the Rat by Giacomo Lazzarino, Angela Maria Amorini, Nicholas M. Barnes, Lars Bruce, Alvaro Mordente, Giuseppe Lazzarino, Valentina Di Pietro, Barbara Tavazzi, Antonio Belli, Ann Logan
Published 2020-09-01
Article -
6
A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis by Ann Logan, Zsuzsanna Nagy, Nicholas M. Barnes, Antonio Belli, Valentina Di Pietro, Barbara Tavazzi, Giuseppe Lazzarino, Giacomo Lazzarino, Lars Bruce, Lennart I. Persson
Published 2022-01-01
Article -
7
T regulatory cells as a potential therapeutic target in psychosis? Current challenges and future perspectives by Fabiana Corsi-Zuelli, Bill Deakin, Mikhael Haruo Fernandes de Lima, Omar Qureshi, Nicholas M. Barnes, Rachel Upthegrove, Paulo Louzada-Junior, Cristina Marta Del-Ben
Published 2021-11-01
Article -
8
The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: New platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis by Ann Logan, Ann Logan, Antonio Belli, Valentina Di Pietro, Barbara Tavazzi, Giacomo Lazzarino, Renata Mangione, Giuseppe Lazzarino, Inés Morano, Omar Qureshi, Lars Bruce, Nicholas M. Barnes, Zsuzsanna Nagy
Published 2022-08-01
Article -
9
A cell-based, SARS-CoV-2 spike protein interaction assay to inform the neutralising capacity of recombinant and patient sera antibodies by Neale Harrison, Lauren Richardson, Chiara Pallini, Ines Morano, Elizabeth Jinks, Jamie Cowley, Hujo Chan, Harriet J. Hill, Aekkachai Tuekprakhon, Zhi Li, Cristina Matas de las Heras, Ana Teodosio, Andrea S. Lavado, Robert Moring, Ayesha Ashraf, Timothy R. Dafforn, Dimitris K. Grammatopoulos, Dimitris K. Grammatopoulos, John Gordon, Catherine A. Brady, Lawrence S. Young, Nicholas M. Barnes, Nicholas M. Barnes, Zania Stamataki, Omar S. Qureshi
Published 2023-08-01
Article -
10
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro by Omar S. Qureshi, Emma J. Sutton, Rosemary F. Bithell, Shauna M. West, Rona M. Cutler, Gillian McCluskey, Graham Craggs, Asher Maroof, Nicholas M. Barnes, David P. Humphreys, Stephen Rapecki, Bryan J. Smith, Anthony Shock
Published 2024-12-01
Article -
11
Hepatocytes Delete Regulatory T Cells by Enclysis, a CD4+ T Cell Engulfment Process by Scott P. Davies, Gary M. Reynolds, Alex L. Wilkinson, Xiaoyan Li, Rebecca Rose, Maanav Leekha, Yuxin S. Liu, Ratnam Gandhi, Emma Buckroyd, Joe Grove, Nicholas M. Barnes, Robin C. May, Stefan G. Hubscher, David H. Adams, Yuehua Huang, Omar Qureshi, Zania Stamataki
Published 2019-11-01
Article -
12
Relaxation of mitochondrial hyperfusion in the diabetic retina via N6-furfuryladenosine confers neuroprotection regardless of glycaemic status by Aidan Anderson, Nada Alfahad, Dulani Wimalachandra, Kaouthar Bouzinab, Paula Rudzinska, Heather Wood, Isabel Fazey, Heping Xu, Timothy J. Lyons, Nicholas M. Barnes, Parth Narendran, Janet M. Lord, Saaeha Rauz, Ian G. Ganley, Tim M. Curtis, Graham R. Wallace, Jose R. Hombrebueno
Published 2024-02-01
Article -
13
Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT by Bill Deakin, John Suckling, Paola Dazzan, Eileen Joyce, Stephen M Lawrie, Rachel Upthegrove, Nusrat Husain, Imran B Chaudhry, Graham Dunn, Peter B Jones, Danuta Lisiecka-Ford, Shôn Lewis, Thomas RE Barnes, Steven CR Williams, Carmine M Pariante, Emma Knox, Richard J Drake, Richard Smallman, Nicholas M Barnes
Published 2019-08-01
Article -
14
Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 Lev... by Fabiana Corsi-Zuelli, Gary Donohoe, Siân Lowri Griffiths, Cristina M. Del-Ben, Andrew J. Watson, Tom Burke, Paris A. Lalousis, Declan McKernan, Derek Morris, John Kelly, Colm McDonald, Saahithh R. Patlola, Carmine Pariante, Nicholas M. Barnes, Golam M. Khandaker, John Suckling, Bill Deakin, Rachel Upthegrove, Maria R. Dauvermann
Published 2025-03-01
Article -
15
Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation by Alexander Roberts, Lindsay Bentley, Tina Tang, Fay Stewart, Chiara Pallini, Joel Juvvanapudi, Graham R. Wallace, Alison J. Cooper, Aaron Scott, David Thickett, Sebastian T. Lugg, Hollie Bancroft, Bridget Hemming, Charlotte Ferris, Gerald Langman, Andrew Robinson, Joanne Chapman, Babu Naidu, Thomas Pinkney, Graham S. Taylor, Kristian Brock, Zania Stamataki, Catherine A. Brady, S. John Curnow, John Gordon, Omar Qureshi, Nicholas M. Barnes
Published 2021-02-01
Article -
16
Antidepressants for the prevention of depression following first-episode psychosis (ADEPP): study protocol for a multi-centre, double-blind, randomised controlled trial by Edward R. Palmer, Siân Lowri Griffiths, Ben Watkins, Tyler Weetman, Ryan Ottridge, Smitaa Patel, Rebecca Woolley, Sarah Tearne, Pui Au, Eleanor Taylor, Zara Sadiq, Hareth Al-Janabi, Barnaby Major, Charlotte Marriott, Nusrat Husain, Mohammad Zia Ul Haq Katshu, Domenico Giacco, Nicholas M. Barnes, James T. R. Walters, Thomas R. E. Barnes, Max Birchwood, Richard Drake, Rachel Upthegrove
Published 2023-10-01
Article -
17
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trial by Sarah E. Herniman, Stephen J. Wood, Golam Khandaker, Paola Dazzan, Carmine M. Pariante, Nicholas M. Barnes, Carl R. Krynicki, Naghmeh Nikkheslat, Rachel C. Vincent, Alex Roberts, Annalisa Giordano, Andrew Watson, John Suckling, Thomas R. E. Barnes, Nusrat Husain, Peter B. Jones, Eileen Joyce, Stephen M. Lawrie, Shôn Lewis, Bill Deakin, Rachel Upthegrove, the BeneMin Study Team
Published 2023-09-01
Article -
18
Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychos... by Stephen Burgess, Peter Jones, Rachel Upthegrove, Carmine Pariante, Graham K Murray, Anthony David, Martin Wilson, Nicholas Barnes, Paola Dazzan, John Suckling, Valeria Mondelli, Muzaffer Kaser, Neil Harrison, Georgios Gkoutos, Golam M Khandaker, Deepak Jadon, James MacCabe, Gary Donohoe, Alice Egerton, Bill Deakin, Jack Rogers, Éimear M Foley, Sian Lowri Griffiths, Alexander Murray, Fabiana Corsi-Zuelli, Hannah Hickinbotham, Ella Warwick, Nicholas M Barnes, Golam Khandaker, David Cotter, Ed Bullmore, Eva Meisenzahl, Joanna Neill, Nikos Koutsouleris, Stephen Wood
Published 2023-03-01
Article